Oncology

Medicine®, a Wolters Kluwer Health publication and one of the most respected and frequently cited journals in general medicine, is pleased to announce the launch of Medicine®: Oncology, an online channel of content specifically dedicated to the publication and distribution of Oncology-related research within Medicine®.

Medicine®: Oncology will consider submissions in the following subject areas:

  • Basic cancer research
  • Cancer detection and diagnosis
  • Cancer prevention
  • Cancer risk factors
  • Cancer treatment
  • Cancer neoplasms
  • Oncology agents
  • Pediatric oncology
  • Radiotherapy

Submissions will be published and indexed under the Medicine® ISSN.

Submit Your Manuscript

​​

Channels

2284 results

Current Filters:

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience

Moore, Assaf; Bar, Yael; Maurice-Dror, Corinne; More

Medicine. 100(25):e26388, June 25, 2021.

Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis

Revilla-Pacheco, Francisco; Rodríguez-Salgado, Pamela; Barrera-Ramírez, Mónica; More

Medicine. 100(25):e26432, June 25, 2021.

A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy

Hirasawa, Yuya; Yoshimura, Kiyoshi; Matsui, Hiroto; More

Medicine. 100(23):e25774, June 11, 2021.

Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients

Liao, Shian; He, Juliang; Liu, Chong; More

Medicine. 100(22):e26219, June 04, 2021.

Argon plasma coagulation with atezolizumab and chemoradiation in lung pleomorphic cancer showed a remarkable response: Case report

Harada, Masanori; Morikawa, Keisuke; Kagoo, Namio; More

Medicine. 100(21):e26149, May 28, 2021.

ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations

Debonis, Silvia Angela; Bongiovanni, Alberto; Pieri, Federica; More

Medicine. 100(20):e25972, May 21, 2021.

A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer

Fukahori, Masaru; Miwa, Keisuke; Murotani, Kenta; More

Medicine. 100(20):e26052, May 21, 2021.

Prominent PD-L1-positive M2 macrophage infiltration in gastric cancer with hyper-progression after anti-PD-1 therapy: A case report

Yamaguchi, Kyoko; Tsuchihashi, Kenji; Tsuji, Kunihiro; More

Medicine. 100(19):e25773, May 14, 2021.

Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer: A nationwide cohort study and meta-analysis

Chen, Po-Huang; Wu, Yi-Ying; Lee, Cho-Hao; More

Medicine. 100(18):e25756, May 07, 2021.

Immune-related adverse events with immune checkpoint inhibitors: Special reference to the effects on the lungs

Hirata, Aya; Saraya, Takeshi; Kobayashi, Fumi; More

Medicine. 100(14):e25275, April 09, 2021.

Long-term oncological outcome in patients with cervical cancer after 3 trimodality treatment (radiotherapy, platinum-based chemotherapy, and robotic surgery)

Trifanescu, Oana Gabriela; Gales, Laurentia Nicoleta; Serbanescu, Georgia Luiza; More

Medicine. 100(13):e25271, April 02, 2021.

Show: